Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Lagerqvist

Showing results (61-70 of 151) with videos related to

Pageof 16
Sort By:
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|August 13, 2021
Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery diseaseTanja Kero, Antti Saraste, Bo Lagerqvist, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 14, 2018
Erratum to: "No improvements in long-term outcome after coronary artery bypass grafting with arterial grafts as a second conduit: a Swedish nationwide registry study" [Eur J Cardiothorac Surg 2018;53(2):448-454]Mikael Janiec, Axel Dimberg, Timo Z Nazari Shafti, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 29, 2017
No improvements in long-term outcome after coronary artery bypass grafting with arterial grafts as a second conduit: a Swedish nationwide registry studyMikael Janiec, Axel Dimberg, Timo Z Nazari Shafti, et al.
American Heart Journal|June 7, 2016
Low real-world early stent thrombosis rates in ST-elevation myocardial infarction patients and the use of bivalirudin, heparin alone or glycoprotein IIb/IIIa inhibitor treatment: A nationwide Swedish registry reportPer Grimfjärd, David Erlinge, Sasha Koul, et al.
The American Journal of Cardiology|October 31, 2013
Treatment patterns and outcomes in patients undergoing percutaneous coronary intervention treated with prasugrel or clopidogrel (from the Swedish Coronary Angiography and Angioplasty Registry [SCAAR])Peter Damman, Christoph Varenhorst, Sasha Koul, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 4, 2017
Unfractionated heparin versus bivalirudin in patients undergoing primary percutaneous coronary intervention: a SWEDEHEART studyPer Grimfjärd, David Erlinge, Sasha Koul, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Stent thrombosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty RegistryBo Lagerqvist, Jörg Carlsson, Ole Fröbert, et al.
Journal of the American College of Cardiology|April 18, 2009
Outcome of drug-eluting versus bare-metal stenting used according to on- and off-label criteriaJörg Carlsson, Stefan K James, Johan Lindbäck, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)Anders Sahlén, Christoph Varenhorst, Bo Lagerqvist, et al.
Journal of the American College of Cardiology|July 31, 2010
Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry)Axel Akerblom, Stefan K James, Michail Koutouzis, et al.
Pageof 16

Showing results (61-70 of 151) with videos related to

Sort By:
Pageof 16
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|August 13, 2021
Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery diseaseTanja Kero, Antti Saraste, Bo Lagerqvist, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 14, 2018
Erratum to: "No improvements in long-term outcome after coronary artery bypass grafting with arterial grafts as a second conduit: a Swedish nationwide registry study" [Eur J Cardiothorac Surg 2018;53(2):448-454]Mikael Janiec, Axel Dimberg, Timo Z Nazari Shafti, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 29, 2017
No improvements in long-term outcome after coronary artery bypass grafting with arterial grafts as a second conduit: a Swedish nationwide registry studyMikael Janiec, Axel Dimberg, Timo Z Nazari Shafti, et al.
American Heart Journal|June 7, 2016
Low real-world early stent thrombosis rates in ST-elevation myocardial infarction patients and the use of bivalirudin, heparin alone or glycoprotein IIb/IIIa inhibitor treatment: A nationwide Swedish registry reportPer Grimfjärd, David Erlinge, Sasha Koul, et al.
The American Journal of Cardiology|October 31, 2013
Treatment patterns and outcomes in patients undergoing percutaneous coronary intervention treated with prasugrel or clopidogrel (from the Swedish Coronary Angiography and Angioplasty Registry [SCAAR])Peter Damman, Christoph Varenhorst, Sasha Koul, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 4, 2017
Unfractionated heparin versus bivalirudin in patients undergoing primary percutaneous coronary intervention: a SWEDEHEART studyPer Grimfjärd, David Erlinge, Sasha Koul, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Stent thrombosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty RegistryBo Lagerqvist, Jörg Carlsson, Ole Fröbert, et al.
Journal of the American College of Cardiology|April 18, 2009
Outcome of drug-eluting versus bare-metal stenting used according to on- and off-label criteriaJörg Carlsson, Stefan K James, Johan Lindbäck, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)Anders Sahlén, Christoph Varenhorst, Bo Lagerqvist, et al.
Journal of the American College of Cardiology|July 31, 2010
Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry)Axel Akerblom, Stefan K James, Michail Koutouzis, et al.
Pageof 16